1. Home
  2. BJ vs RPRX Comparison

BJ vs RPRX Comparison

Compare BJ & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJ
  • RPRX
  • Stock Information
  • Founded
  • BJ 1984
  • RPRX 1996
  • Country
  • BJ United States
  • RPRX United States
  • Employees
  • BJ N/A
  • RPRX N/A
  • Industry
  • BJ Department/Specialty Retail Stores
  • RPRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BJ Consumer Discretionary
  • RPRX Health Care
  • Exchange
  • BJ Nasdaq
  • RPRX Nasdaq
  • Market Cap
  • BJ 13.8B
  • RPRX 14.0B
  • IPO Year
  • BJ 2018
  • RPRX 2020
  • Fundamental
  • Price
  • BJ $101.56
  • RPRX $33.42
  • Analyst Decision
  • BJ Buy
  • RPRX Strong Buy
  • Analyst Count
  • BJ 16
  • RPRX 6
  • Target Price
  • BJ $95.81
  • RPRX $41.67
  • AVG Volume (30 Days)
  • BJ 1.4M
  • RPRX 4.6M
  • Earning Date
  • BJ 03-06-2025
  • RPRX 02-11-2025
  • Dividend Yield
  • BJ N/A
  • RPRX 2.63%
  • EPS Growth
  • BJ 11.42
  • RPRX N/A
  • EPS
  • BJ 4.17
  • RPRX 1.91
  • Revenue
  • BJ $20,580,562,000.00
  • RPRX $2,263,576,000.00
  • Revenue This Year
  • BJ $6.15
  • RPRX $29.18
  • Revenue Next Year
  • BJ $6.31
  • RPRX $9.99
  • P/E Ratio
  • BJ $24.17
  • RPRX $17.52
  • Revenue Growth
  • BJ 5.32
  • RPRX N/A
  • 52 Week Low
  • BJ $69.10
  • RPRX $24.05
  • 52 Week High
  • BJ $108.00
  • RPRX $33.69
  • Technical
  • Relative Strength Index (RSI)
  • BJ 50.04
  • RPRX 78.16
  • Support Level
  • BJ $104.73
  • RPRX $32.28
  • Resistance Level
  • BJ $108.00
  • RPRX $33.69
  • Average True Range (ATR)
  • BJ 2.70
  • RPRX 0.69
  • MACD
  • BJ -0.48
  • RPRX -0.02
  • Stochastic Oscillator
  • BJ 43.41
  • RPRX 89.85

About BJ BJ's Wholesale Club Holdings Inc.

BJ's Wholesale serves as one of the few warehouse club chains in the United States. Its more than 240 warehouses are primarily located along the East Coast, most prominently in the New England area. Similar to its warehouse club peers, BJ's charges annual membership fees and keeps costs down by operating a "no-frills" store environment. The company limits the use of distribution centers where possible and stores inventory on pallets directly on the sales floor, often in bulk quantities. The company also offers a limited assortment of 7,000 stock-keeping units at its warehouses to achieve greater procurement scale on select items. About 80% of BJ's net sales come from grocery items and general merchandise, with the remaining 20% coming from gasoline and other ancillary services.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: